A comparison of the antagonistic activities of tamsulosin and terazosin against human vascular α1-adrenoceptors

被引:24
作者
Harada, K [1 ]
Ohmori, M [1 ]
Kitoh, Y [1 ]
Sugimoto, K [1 ]
Fujimura, A [1 ]
机构
[1] Jichi Med Sch, Dept Clin Pharmacol, Minami Kawachi, Tochigi 3290498, Japan
关键词
tamsulosin; terazosin; alpha(1)-adrenoceptor; blood vessel; human study;
D O I
10.1254/jjp.80.209
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tamsulosin, a selective alpha(1A)-adrenoceptor antagonist, and terazosin, a non-selective one, are effective for the treatment of urinary disturbance due to benign prostatic hypertrophy. In the present study, their al-adrenoceptor-blocking effects on blood vessels, which may cause orthostatic hypotension, were investigated in 10 healthy males. After the subjects took orally 0.2 mg of tamsulosin, 1 mg of terazosin or a lactate capsule as the control in a randomized cross-over fashion, their finger tip vasoconstrictor response to cold stimulation and vasoconstrictor response of the dorsal hand vein to increasing doses of phenylephrine were examined. The finger tip vasoconstrictor response was significantly reduced and the infusion rate of phenylephrine producing a half-maximal constriction was significantly increased by terazosin, but tamsulosin had no significant effect on these parameters. These data suggest that the usual dose of tamsulosin exerts little alpha(1)-adrenoceptor-blocking activity on blood vessels, and orthostatic episodes might be mild, if any, during the treatment with tamsulosin.
引用
收藏
页码:209 / 215
页数:7
相关论文
共 39 条
[1]   A NEW TECHNIQUE FOR RECORDING COMPLIANCE OF HUMAN HAND VEINS [J].
AELLIG, WH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) :237-243
[2]   EVALUATION AND APPLICATION OF THE LINEAR VARIABLE DIFFERENTIAL TRANSFORMER TECHNIQUE FOR THE ASSESSMENT OF HUMAN DORSAL HAND VEIN ALPHA-RECEPTOR ACTIVITY [J].
ALRADI, AO ;
CARRUTHERS, SG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :495-502
[3]  
Beduschi R, 1998, GERIATRICS, V53, P24
[4]  
Brawer M K, 1993, Arch Fam Med, V2, P929, DOI 10.1001/archfami.2.9.929
[5]  
BURKE D, 1997, J PHYSIOL-LONDON, V272, P399
[6]  
Chapple CR, 1996, EUR UROL, V29, P155
[7]  
EBIHARA A, 1987, J CLIN THER MED, V3, P667
[8]  
EBIHARA A, 1987, J CLIN THER MED, V3, P681
[9]  
FELLOWS IW, 1985, CLIN SCI, V69, P215, DOI 10.1042/cs0690215
[10]   USE OF RECOMBINANT ALPHA(1)-ADRENOCEPTORS TO CHARACTERIZE SUBTYPE SELECTIVITY OF DRUGS FOR THE TREATMENT OF PROSTATIC HYPERTROPHY [J].
FOGLAR, R ;
SHIBATA, K ;
HORIE, K ;
HIRASAWA, A ;
TSUJIMOTO, G .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 288 (02) :201-207